サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485750

RNA干渉技術市場：タイプ別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

RNA Interference Technology Market, By Type, By Application, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 379 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
RNA干渉技術市場：タイプ別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年05月11日
発行: AnalystView Market Insights
ページ情報: 英文 379 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

RNA干渉技術市場規模は2023年に15億4,562万米ドルとなり、2024～2032年にかけて16.5%のCAGRで拡大

RNA干渉技術市場-市場力学

精密医療の進歩におけるRNA干渉技術の役割

RNA干渉（RNAi）技術は、個別化治療の選択肢を提供することで精密医療を進める上で極めて重要です。例えば、米国国立衛生研究所（NIH）の研究者は、がんに関与する特定の遺伝子を標的とするためにRNAiを利用し、腫瘍抑制や個別化治療アプローチにおいて有望な結果を示しています。さらに、アルナイラム・ファーマシューティカルズのような製薬会社は、希少な遺伝性疾患のためにRNAiベースの治療を開発しており、個々の患者のニーズに対応するRNAiの変革の可能性を例証しています。この技術は、患者固有の遺伝子プロファイルに合わせた正確な遺伝子サイレンシングを可能にし、有効性を高め副作用を低減した標的療法の開発を促進することで、個別化医療の展望を一変させる。

RNA干渉技術市場-主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約16.5%のCAGRで毎年成長すると予測されています。

タイプ別セグメンテーションでは、siRNAが2023年に最大の市場シェアを示すと予測されています。

用途別では、2023年に治療が主要なタイプでした。

地域別では、北米が2023年に主要な収益源となりました。

RNA干渉技術市場-セグメンテーション分析：

RNA干渉技術の世界市場は、タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

タイプ別では、dsRNA、siRNA、miRNAの3つに分類されます。短鎖干渉RNA（siRNA）は、その特異性と遺伝子サイレンシングにおける有効性により最も高い嗜好性を保持しており、次いでマイクロRNA（miRNA）は、遺伝子発現における制御的役割で知られています。二本鎖RNA（dsRNA）はオフ対象効果や自然免疫反応のため、あまり好まれないです。

市場は用途によって3つのカテゴリーに分けられます：創薬・医薬品開発、治療、農作物改良です。治療は、精密医療や個別化治療におけるRNAiベースの治療に対する需要の増加により、最高位にランクされています。創薬・開発セグメントでは、標的の検証や薬剤スクリーニングにRNAi技術が活用され、僅差で続いています。農作物の改変やその他の用途は、規制上の課題や市場の複雑さにより、選好度が低いです。

RNA干渉技術市場-地理的洞察

北米、特に米国は、Alnylam PharmaceuticalsやArrowhead Pharmaceuticalsのような主要参入企業に支えられ、バイオテクノロジーと製薬セクターにおける活発な研究開発活動で市場をリードしています。欧州では、ドイツ、英国、スイスなどの国々が、産学連携に支えられた強力な生物医療研究と臨床応用を通じて採用を推進しています。アジア太平洋は、中国、日本、インドなどの国々における医療費の増加、バイオテクノロジー研究への投資、ゲノム医療に対する政府の支援によって、急速な成長を示しています。ラテンアメリカは、精密医療と遺伝子治療への注力に後押しされ、医療インフラの改善と規制の整備が市場開拓を後押ししています。中東・アフリカも、医療インフラへの投資と個別化医療に対する意識の高まりに支えられ、共同研究によって技術移転と市場開拓が促進され、成長が見込まれています。

RNA干渉技術市場-競合情勢：

Alnylam Pharmaceuticals、Arrowhead Pharmaceuticals、Dicerna Pharmaceuticals、Quark Pharmaceuticals、Silence Therapeuticsなど複数の主要企業が、RNAiベースの治療の技術革新と製品開発を推進しています。Alnylam Pharmaceuticalsは希少遺伝性疾患への注力で際立っており、Arrowhead Pharmaceuticalsは肝疾患やがんに対するRNAiベースの医薬品を専門としています。注目すべき提携例としては、Alnylam PharmaceuticalsがRegeneron Pharmaceuticalsと提携し、AlnylamのRNAi治療に関する専門知識とRegeneron Pharmaceuticalsの抗体技術を活用して、眼疾患と中枢神経系疾患に対するRNAiベースの治療を開発していることが挙げられます。Dicerna Pharmaceuticalsは独自のRNAi技術プラットフォームを様々な疾患経路に活用し、Quark Pharmaceuticalsは眼疾患と腎障害に注力しています。Silence Therapeuticsは、高度なデリバリーシステムを用いて、心血管系疾患、がん、希少遺伝性疾患に対するRNAi療法を開発しています。これらの企業は、技術的進歩、治療パイプライン、学術・製薬パートナーとの戦略的提携で競争しており、RNAiベースの治療法の有効性と安全性を実証するための研究や臨床試験が進行中のダイナミックな市場環境を反映しています。

目次

第1章 RNA干渉技術市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 RNA干渉技術の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 RNA干渉技術産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 RNA干渉技術市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 RNA干渉技術市場情勢

  • RNA干渉技術市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 RNA干渉技術市場-タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 二本鎖RNA
    • siRNA
    • マイクロRNA

第8章 RNA干渉技術市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 医薬品の発見と開発
    • 治療
    • 農作物の改良
    • その他

第9章 RNA干渉技術市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬会社
    • バイオテクノロジー企業
    • 契約研究機関
    • 学術界
    • 研究センター
    • その他

第10章 RNA干渉技術市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-RNA干渉技術業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Alnylam Pharmaceuticals, Inc.
    • Arbutus Biopharma Corporation
    • Arrowhead Pharmaceuticals, Inc.
    • Benitec Biopharma Limited
    • DicereGen, Inc.
    • Dicerna Pharmaceuticals, Inc.
    • Gradalis, Inc.
    • Ionis Pharmaceuticals, Inc.
    • miRagen Therapeutics, Inc.
    • Quark Pharmaceuticals, Inc.
    • Regulus Therapeutics Inc.
    • RXi Pharmaceuticals Corporation
    • Silence Therapeutics plc
    • Sirnaomics, Inc.
    • Sylentis SAU（PharmaMar Group）
    • Tacere Therapeutics, Inc.
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Interference Technology Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global RNA Interference Technology Market, by Type 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global RNA Interference Technology Market, by Application 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: End-Users Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global RNA Interference Technology Market, by End-Users 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Interference Technology Market, by Region 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
目次
Product Code: ANV2648

REPORT HIGHLIGHT

RNA Interference Technology Market size was valued at USD 1,545.62 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The RNA interference (RNAi) technology market involves using small RNA molecules to silence gene expression, with applications in gene therapy, drug discovery, and functional genomics. Increasing demand for precise therapies in personalized medicine, and advancements in drug delivery systems enabling efficient RNAi-based treatments are driving the demand for the market. However, challenges such as off-target effects, and delivery complexities impede market growth. Opportunities exist in applying RNAi to neurodegenerative diseases, forming partnerships for innovative therapies and delivery methods, and entering untapped markets in developing regions with rising healthcare investment and research activity, promising prospects for RNAi technology adoption.

RNA Interference Technology Market- Market Dynamics

RNA Interference Technology's Role in Advancing Precision Medicine

RNA interference (RNAi) technology is pivotal in advancing precision medicine by offering personalized treatment options. For instance, researchers at the National Institutes of Health (NIH) have utilized RNAi to target specific genes implicated in cancer, demonstrating promising results in tumor suppression and personalized therapy approaches. Additionally, pharmaceutical companies like Alnylam Pharmaceuticals have developed RNAi-based therapeutics for rare genetic disorders, exemplifying the transformative potential of RNAi in addressing individual patient needs. This technology enables precise gene silencing tailored to patient-specific genetic profiles, facilitating the development of targeted therapies with enhanced efficacy and reduced side effects, thereby revolutionizing the landscape of personalized medicine.

RNA Interference Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, siRNA was predicted to show maximum market share in the year 2023

Based on application segmentation, therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

RNA Interference Technology Market- Segmentation Analysis:

The Global RNA Interference Technology Market is segmented based on Type, Application, End-Users, and Region.

The market is divided into three categories based on Type: dsRNA, siRNA, and miRNA. Short interfering RNA (siRNA) holds the highest preference due to its specificity and effectiveness in gene silencing, followed by microRNA (miRNA), known for its regulatory role in gene expression. Double-stranded RNA (dsRNA) is less favored due to off-target effects and innate immune responses.

The market is divided into three categories based on application: Drug Discovery and Development, Therapeutics, and Agricultural Crop Modifications. Therapeutics ranks highest, driven by increasing demand for RNAi-based treatments in precision medicine and personalized therapies. Drug discovery and development follow closely, leveraging RNAi technology for target validation and drug screening. Agricultural crop modifications and other applications exhibit lower preference due to regulatory challenges and market complexity.

RNA Interference Technology Market- Geographical Insights

North America, particularly the United States, leads the market with robust research and development activities in the biotechnology and pharmaceutical sectors, supported by key players like Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals. In Europe, countries such as Germany, the UK, and Switzerland drive adoption through strong biomedical research and clinical applications, bolstered by academic-industry collaborations. The Asia Pacific region shows rapid growth, driven by increasing healthcare expenditure, biotechnology research investments, and governmental support for genomic medicine in countries like China, Japan, and India. Latin America presents opportunities fueled by the focus on precision medicine and genetic therapies, with improving healthcare infrastructure and regulatory developments aiding market expansion. The Middle East and Africa also see growth, supported by healthcare infrastructure investments and rising awareness about personalized medicine, with collaborations enhancing technology transfer and market development in the region.

RNA Interference Technology Market- Competitive Landscape:

Several key players such as Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Quark Pharmaceuticals, and Silence Therapeutics, all drive innovation and product development in RNAi-based therapeutics. Alnylam Pharmaceuticals stands out for its focus on rare genetic diseases, while Arrowhead Pharmaceuticals specializes in RNAi-based drugs for liver diseases and cancer. Notable instances of collaboration include Alnylam Pharmaceuticals' partnership with Regeneron Pharmaceuticals to develop RNAi-based treatments for ocular and CNS diseases, leveraging Alnylam's expertise in RNAi therapeutics and Regeneron's capabilities in antibody technologies. Dicerna Pharmaceuticals leverages its proprietary RNAi technology platform for various disease pathways, and Quark Pharmaceuticals focuses on ocular diseases and kidney injuries. Silence Therapeutics develops RNAi therapies for cardiovascular diseases, cancer, and rare genetic disorders using advanced delivery systems. These companies compete on technological advancements, therapeutic pipelines, and strategic collaborations with academic and pharmaceutical partners, reflecting a dynamic market landscape with ongoing research and clinical trials to demonstrate the efficacy and safety of RNAi-based therapies.

Recent Developments:

In April 2024, Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia.

In June 2023, Canada's Pest Management Research Agency approved a field study for RNAi biopesticide delivery technology, which is an eco-friendly way to protect crops from insects.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alnylam Pharmaceuticals, Inc.

Arbutus Biopharma Corporation

Arrowhead Pharmaceuticals, Inc.

Benitec Biopharma Limited

DicereGen, Inc.

Dicerna Pharmaceuticals, Inc.

Gradalis, Inc.

Ionis Pharmaceuticals, Inc.

miRagen Therapeutics, Inc.

Quark Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

RXi Pharmaceuticals Corporation

Silence Therapeutics plc

Sirnaomics, Inc.

Sylentis S.A.U. (PharmaMar Group)

Tacere Therapeutics, Inc.

Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • dsRNA
  • siRNA
  • miRNA

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery and Development
  • Therapeutics
  • Agricultural Crop Modifications
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Academia
  • Research Centers
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.RNA Interference Technology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.RNA Interference Technology Market Snippet by Type
    • 2.1.2.RNA Interference Technology Market Snippet by Application
    • 2.1.3.RNA Interference Technology Market Snippet by End-Users
    • 2.1.4.RNA Interference Technology Market Snippet by Country
    • 2.1.5.RNA Interference Technology Market Snippet by Region
  • 2.2.Competitive Insights

3.RNA Interference Technology Key Market Trends

  • 3.1.RNA Interference Technology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.RNA Interference Technology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.RNA Interference Technology Market Opportunities
  • 3.4.RNA Interference Technology Market Future Trends

4.RNA Interference Technology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.RNA Interference Technology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.RNA Interference Technology Market Landscape

  • 6.1.RNA Interference Technology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.RNA Interference Technology Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.dsRNA
    • 7.1.3.siRNA
    • 7.1.4.miRNA

8.RNA Interference Technology Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Discovery and Development
    • 8.1.3.Therapeutics
    • 8.1.4.Agricultural Crop Modifications
    • 8.1.5.Others

9.RNA Interference Technology Market - By End-Users

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Users, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical Companies
    • 9.1.3.Biotechnology Companies
    • 9.1.4.Contract Research Organizations
    • 9.1.5.Academia
    • 9.1.6.Research Centers
    • 9.1.7.Others

10.RNA Interference Technology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.RNA Interference Technology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.RNA Interference Technology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.RNA Interference Technology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.RNA Interference Technology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.RNA Interference Technology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- RNA Interference Technology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Alnylam Pharmaceuticals, Inc.
    • 11.2.2.Arbutus Biopharma Corporation
    • 11.2.3.Arrowhead Pharmaceuticals, Inc.
    • 11.2.4.Benitec Biopharma Limited
    • 11.2.5.DicereGen, Inc.
    • 11.2.6.Dicerna Pharmaceuticals, Inc.
    • 11.2.7.Gradalis, Inc.
    • 11.2.8.Ionis Pharmaceuticals, Inc.
    • 11.2.9.miRagen Therapeutics, Inc.
    • 11.2.10.Quark Pharmaceuticals, Inc.
    • 11.2.11.Regulus Therapeutics Inc.
    • 11.2.12.RXi Pharmaceuticals Corporation
    • 11.2.13.Silence Therapeutics plc
    • 11.2.14.Sirnaomics, Inc.
    • 11.2.15.Sylentis S.A.U. (PharmaMar Group)
    • 11.2.16.Tacere Therapeutics, Inc.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us